Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Clean Biologics SAS acquires Biodextris Inc.
Clean Biologics, a group providing services to the biopharmaceutical industry, today announces the acquisition of […]
Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced […]
Cumulus Neuroscience Announces £6 million Funding Round
Cumulus Neuroscience (Cumulus, The Company), formerly known as BrainWaveBank, announces a £6m financing round led […]
EU Commission Approves Benlysta for Lupus Nephritis
GlaxoSmithKline plc (GSK) today announced the European Commission has approved the expanded use of intravenous […]
ViiV Healthcare New Drug Application for Long-Acting Cabotegravir for Prevention of HIV
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer […]
AI Powered Eye-Test a ‘Healthcare Game-changer’
In an Australian first, Bupa Optical customers can access innovative Artificial Intelligence (AI) enabled eye […]
Robocath Completes First Robotic Angioplasties in Belgium
Robocath, a company that designs, develops and commercializes cardiovascular robotic platforms for the treatment of […]
Healthcare Gamification Market to Grow at an Impressive Rate
According to TechSci Research, “Global Healthcare Gamification Market By Product (Consumer Based Solutions v/s Enterprise-based […]
DNA: New Method Analyses Changes with ‘Unprecedented Accuracy’
Scientists have developed a new sequencing method to study changes in the DNA of any […]
Transforming the UK into a Life Sciences Superpower
Patients are set to benefit from better research, treatment, care and improved clinical decision-making, as […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more